Semaglutide Patent Expiry: The Next Big Unlock in Global Pharma
India's pharma industry prepares for Semaglutide patent expiry in 2026, offering a high-potential market opportunity for Indian players like Natco...
615 Views
(Mostly) Asia M&A: October 2019 Roundup
For the month of October, 17 new deals were discussed on Smartkarma with an overall announced deal size of ~US$34bn. Clicking on the company...
620 Views
(Mostly) Asia M&A: September 2019 Roundup
For the month of September, 12 new deals were discussed on Smartkarma with an overall announced deal size of ~US$250bn, aided by the mega-merger of...
643 Views
(Mostly) Asia M&A: August 2019 Roundup
For the month of August, 16 new deals were discussed on Smartkarma with an overall announced deal size of ~US$23bn. Clicking on the company name in...
661 Views
MergerTalk: Pfizer/Mylan -Don't Overdose on the Sector, but Mylan Over Teva Pair Trade Is Still On
The recently announced Reverse Morris Trust transaction involving the merger of Pfizer's (PFE US) off-patent business (Upjohn) with Mylan (MYL US)...
553 Views